@FiercePharma: Spanish drugmakers can't grow at home, so they're looking for international expansion--Bloomberg. More | Follow @FiercePharma
> GlaxoSmithKline ($GSK) is lining up 12 nominees to replace Human Genome Sciences' ($HGSI) entire board, but will wait till HGS' auction process wraps up before it makes another move toward taking over the company. Report
> Johnson & Johnson ($JNJ) pulled its application to extend use of Velcade, its blood cancer drug, for use in lymphoma patients. Report
> Sanofi ($SNY) plans to sell its 19.8% stake in Yves Rocher, a consumer products company that sells cosmetics, home care products and clothing. Report
> Slovenia's Krka said sales grew by 7% during the first half of 2012 to $707 million, aided by a 24% rise in Russian revenues. Report
> Lupin won FDA approval to sell its version of the Pfizer ($PFE) nerve-pain drug Lyrica. Report
> European regulators expanded approval for Eisai's epilepsy drug Zonegran to include its use on its own, rather than as an add-on to other treatments. Report
> Cardiome Pharma ($CRME) said CEO Doug Janzen left the company and will be replaced for now by interim CEO William Hunter. Report
> Dendreon ($DNDN) CEO John Johnson officially took over the chairman's role at the company. Report
Biotech News
@FierceBiotech: Nanofactories can synthesize drugs within the body. More | Follow @FierceBiotech
@JohnCFierce: Roche move spotlights NJ's shrinking role in biopharma R&D. Article | Follow @JohnCFierce
@RyanMFierce: Software could provide a new measuring tool for Parkinson's during clinical trials. Story | Follow @RyanMFierce
> Sanofi sharpens R&D budget ax as it prepares to cut up to 2,000 jobs. News
> Dr. Reddy's maps out ambitious global plans for biosimilars. Article
> CEO at troubled Cardiome exits in midst of reorganization. Story
Medical Device News
@FierceMedDev: We have extended the nomination deadline for the 15 fiercest medical device developers to July 13. Spread the word. Survey | Follow @FierceMedDev
@DamianFierce: MDxHealth has signed a deal with Merck KGaA to provide companion diagnostics for a pipeline cancer drug. More | Follow @DamianFierce
> FDA says device-ID plan a 'game-changer.' Story
> Israeli devicemaker launches smartphone that monitors vitals. Article
> FDA approves OraSure's at-home HIV test. News
Vaccines News
> In $69M IPO bid, GlobeImmune spotlights therapeutic vaccines. Story
> Group tackles dengue vaccine pricing. More
> Soligenix, Infectious Disease Research Institute partner to combat anthrax. Article
> FDA gives Argos green light for kidney cancer immunotherapy. News
Pharma Manufacturing News
@EricPFierce: China tainted drug capsule scandal leads to new responsibilities for drugmakers. Report | Follow @EricPFierce
> FDA gets device, but not drug tracking .More
> Budget chainsaw may miss Sanofi manufacturing. News
> Glaxo manufacturing must meet special dictates. Story
CRO News
@NesaNFierce: Argentina is becoming more than the birthplace of Tango, growing in terms of outsourcing. More | Follow @NesaNFierce
> Pernix Therapeutics offers $4.9M for CMO Great Southern Laboratories. Story
> ScinoPharm to build $37M Taiwan plant for cancer injectables. Article
> CMO execs reflect on changing manufacturing front. More
Drug Delivery News
> UPenn turns plant protein into drug-delivery tech. Item
> pSivida eyes FDA approval with trial for Durasert-delivered drug. Story
> InVivo looks to get gel-delivered pain drug on U.S. market. Article
> Northwestern docs deliver siRNA with lotion to stymie cancer. More
> Researchers develop gel to deliver male contraceptive. Story
And Finally... Teach an old bee new tricks, and its brain starts acting younger, researchers found. Report